Financial Health Assessment: MANUPACKAGING U.K. LTD

1. Financial Health Score: B- (Incomplete Examination)

Explanation: The patient is alive, stable, and exhibits excellent outward signs of corporate hygiene. With over 30 years of operational history, robust share capital, and perfect compliance, the structural health is strong. However, the grade is currently incomplete because the patient has arrived for the checkup without their blood work—we are missing the core financial statements (Profit & Loss, Balance Sheet details) necessary to check for underlying conditions like poor cash flow or excessive debt.

2. Key Vital Signs

• Corporate Longevity (Pulse): Strong. Incorporated in 1992, this business has a 30-plus-year heartbeat. Surviving multiple economic cycles indicates a resilient business model and strong market demand for its plastic packing goods.
• Compliance Health (Blood Pressure): Excellent. The company’s filings are completely up to date, with the last confirmation statement made up in October 2025 and accounts not overdue. Filing "Full" accounts rather than taking small-company exemptions requires more transparency, showing a healthy, low-stress approach to regulatory compliance.
• Capital & Ownership (Bone Density & Genetics): Robust. The business has a substantial share capital of £370,000, providing a strong structural foundation. The PSC register shows deeply entrenched, stable ownership split primarily between Mr. Sandro Manuli (50-75% control) and Mr. Stefano Visalli (25-50% control). This is not a fly-by-night operation; it has the "genetic" backing of a long-term, likely international, family or corporate dynasty.
• Financial Metrics (Blood Work): MISSING. Without the turnover, net current assets, and P&L reserve figures, we cannot measure the company's financial anemia (liquidity) or cholesterol (debt levels).

3. Diagnosis

Condition: Asymptomatic but clinically opaque.

Based on the observable symptoms, MANUPACKAGING U.K. LTD is in good structural health. The presence of multiple directors, including Italian nationals, alongside the PSC ownership, strongly suggests this entity operates as the UK limb of a larger, international group (the Manuli group). This group backing acts as a powerful immune system against localized market shocks.

The company underwent a corporate "skin graft" in 2019, changing its name from MANULI PACKAGING (UK) LTD to MANUPACKAGING U.K. LTD. This rebranding appears to have been a healthy, cosmetic evolution rather than a distress-driven pivot, as the core business (manufacture of plastic packing goods) remained intact.

However, because the detailed financial lab results are missing from this examination, we must rule out silent killers. In the manufacturing sector, we frequently look for symptoms of working capital distress—whereby a company has a healthy pulse (sales) but suffocates slowly because cash is tied up in stock or debtors, and it cannot pay its short-term creditors (current liabilities). Without the net current assets figure, we cannot confirm the absence of this condition.

4. Recommendations

1. Complete the Diagnostic Panel: Retrieve the full, filed annual accounts from Companies House to analyze the balance sheet and profit and loss statements. You must check the "working capital ratio" (Current Assets vs. Current Liabilities) to ensure the company is not suffering from cash flow anemia.
2. Check the Group's Health: Because this company appears to be a subsidiary of a larger international group, the financial wellness of the UK entity is intrinsically linked to the parent. Investigate whether inter-company loans exist on the balance sheet, which could indicate either financial life support (loans from the parent) or bloodletting (excessive cash extraction by the parent).
3. Monitor Industry-Specific Risks: As a manufacturer of plastic packing goods, the company is vulnerable to fluctuating raw material costs (petrochemicals) and increasing environmental regulations regarding single-use plastics. Ensure the business has a strategic "vaccination" plan—such as investment in recyclable or sustainable packaging innovations—to protect against future market obsolescence.
4. Maintain Corporate Hygiene: Continue the excellent track record of timely filings and transparent governance. The current board structure, including a dedicated company secretary (Emma Brown), is a best practice that keeps the company's regulatory immune system strong.